Animal models of psoriasis and psoriatic arthritis: An update

Current Rheumatology Reports

Volumn 8, Issue 5, 2006, Pages 342-347

  Conrad, Curdin ^a   Nestle, Frank O ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BONE MORPHOGENETIC PROTEIN;

ANGIOGENESIS; CELL DIFFERENTIATION; CELLULAR IMMUNITY; DENDRITIC CELL; DNA MODIFICATION; HUMAN; IMMUNE SYSTEM; KERATINOCYTE; NONHUMAN; PATHOGENESIS; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; T LYMPHOCYTE; XENOTRANSPLANTATION;

ANIMALS; ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; CYTOKINES; DISEASE MODELS, ANIMAL; IMMUNITY, CELLULAR; KERATINOCYTES; PSORIASIS; T-LYMPHOCYTES;

EID: 33750388473     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-006-0063-x     Document Type: Review

References (26)

1. Nickoloff BJ, Nestle FO: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 2004, 113:1664-1675.
2. Davidson A, Diamond B: Autoimmune diseases. N Engl J Med 2001, 345:340-350.
3. Nestle FO, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J Clin Invest 1994, 94:202-209.
4. Krueger GG, Bergstresser PR, Lowe NJ, et al.: Psoriasis. J Am Acad Dermatol 1984, 11:937-947.
5. Barker JN: The pathophysiology of psoriasis. Lancet 1991, 338:227-230.
6. Ackermann L, Harvima IT, Pelkonen J, et al.: Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol 1991, 140:624-633.
7. Lowe PM, Lee ML, Jackson CJ, et al.: The endothelium in psoriasis. Br J Dermatol 1995, 132:497-505.
8. Nickoloff BJ: The immunologic and genetic basis of psoriasis. Arch Dermatol 1999, 135:1104-1110.
9. Gottlieb AB: Immunologic mechanisms in psoriasis. J Am Acad Dermatol 1988, 18:1376-1380.
10. Chang JC, Smith LR, Froning KJ, et al.: Persistence of T-cell clones in psoriatic lesions. Arch Dermatol 1997, 133:703-708.
11. Vollmer S, Menssen A, Prinz JC: Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris. J Invest Dermatol 2001, 117:1296-1301.
12. Wrone-Smith T, Nickoloff BJ: Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996, 98:1878-1887.
13. Boehncke WH, Dressel D, Zollner TM, Kaufmann R: Pulling the trigger on psoriasis. Nature 1996, 379:777.
14. Boyman O, Hefti HP, Conrad C, et al.: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med 2004, 199:731-736. Xenotransplantation psoriasis model with spontaneous development of psoriasis in a T-cell and TNF-α dependent manner.
15. Zenz R, Eferl R, Kenner L, et al.: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375. Epidermal deletion of AP-I proteins leads to psoriasiform skin inflammation and arthritis. Arthritis lesions are dependent on T cells and TNFR signaling.
16. Schon MP: Animal models of psoriasis-what can we learn from them? J Invest Dermatol 1999, 112:405-410.
17. Haider AS, Duculan J, Whynot JA, Krueger JG: Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. J Invest Dermatol 2006, 126:912-914.
18. Gottlieb SL, Gilleaudeau P, Johnson R, et al.: Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995, 1:442-447.
19. Sano S, Chan KS, Carbajal S, et al.: Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 2005, 11:43-49. Expression of activated STAT3 in mouse epidermis leads to T cell dependent psoriasiform skin inflammation showing that keratinocytes and immune cells interdependently participate in psoriasis pathogenesis.
20. Nickoloff BJ, Wrone-Smith T: Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999, 155:145-158.
21. Nickoloff BJ, Bonish B, Huang BB, Porcelli SA: Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system. J Dermatol Sci 2000, 24:212-225.
22. Gilhar A, Ullmann Y, Kerner H, et al.: Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002, 119:384-391.
23. Boyman O, Conrad C, Dudli C, et al.: Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. Br J Dermatol 2005, 152:1211-1218.
24. Nestle FO, Conrad C, Tun-Kyi A, et al.: Plasmacytoid pre-dendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005, 202:135-143. IFN-α produced by plasmacytoid predendritic cells is identified as a major innate driver of the inflammatory disease process in psoriasis.
25. Blessing M, Schirmacher P, Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J Cell Biol 1996, 135:227-239.
26. Hammer RE, Maika SD, Richardson JA, et al.: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990, 63:1099-1112.